Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

NCT00596752 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

840

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Occlusive Disease

Interventions

DRUG: Alprostadil
OTHER: Placebo

Sponsor

UCB BIOSCIENCES GmbH

Collaborators

[object Object]